Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study reveals hidden costs of premature baby care

NCT ID NCT07192393

Knowledge-focused Sponsor: Imperial College London Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This UK study follows 90 families of very premature babies (born before 30 weeks) for one year after hospital discharge. It measures how caring for a baby with or without necrotising enterocolitis (NEC)—a serious bowel disease—affects the family's finances, emotions, and quality of life. Parents fill out questionnaires at three time points to capture health, wellbeing, and out-of-pocket costs. The results will help the NHS decide whether certain feeding practices during blood transfusions are worth adopting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could provide clear evidence on the true costs and emotional toll of caring for premature babies with NEC, helping shape better NHS policies and family support.
What could go wrong
This is a small observational study (90 families) that only measures outcomes—it does not test a new treatment. Results may not apply to all families or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Oct 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Parents of 90 babies will be recruited. We have identified at least 9 high-volume recruiting sites for the WHEAT International trial, including 3 regional neonatal surgical units. These sites collectively care for over 300 eligible babies and over 100 babies with NEC annually. Our site selection ensures a diverse sample of parents, representing various socioeconomic and ethnic backgrounds, with all sites located in areas of both affluence and deprivation.

Ages

Up to 30 weeks

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Preterm birth \<30 gestational weeks Exclusion Criteria: * Parent(s) of a preterm baby who died of necrotising enterocolitis (NEC) * Parent(s) unwilling or unable to provide written informed consent * Parent(s) and sibling(s) unable to understand English.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Necrotising enterocolitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

necrotizing enterocolitis Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Necrotising enterocolitis Prematurity; decision support Prematurity; extreme Preterm Preterm birth Preterm infant health

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Chelsea & Westminster Hospital

    RECRUITING

    London, United Kingdom

  • Imperial College Healthcare NHS Trust (St Mary's Hospital, Paddington)

    RECRUITING

    London, United Kingdom

  • John Radcliffe Hospital

    RECRUITING

    Oxford, United Kingdom

  • Liverpool Women's Hospital

    RECRUITING

    Liverpool, United Kingdom

  • Norfolk and Norwich University Hospital

    RECRUITING

    Norwich, Norfolk, United Kingdom

  • Queen Alexandra Hospital

    RECRUITING

    Portsmouth, United Kingdom

  • University Hospital Coventry

    RECRUITING

    Coventry, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.